Status:
UNKNOWN
PTC Drug Sensitivity Detection to Guide Postoperative Adjuvant of Colorectal Cancer
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Colo-rectal Cancer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The research objectives is to compare vitro 3D drug sensitivity test results of micro tumor (PTC) with the clinical outcomes of patients, evaluate the consistency between the test results of the techn...
Detailed Description
The study is a multi agency prospective cohort study in China. The subjects were patients aged 18 \~ 75 years with colorectal cancer diagnosed by histopathology or cytology. They must be colorectal ca...
Eligibility Criteria
Inclusion
- Age 18 \~ 75 years old, regardless of gender
- Patients with colorectal cancer diagnosed by histopathology or cytology
- Colorectal cancer patients who need adjuvant therapy after radical surgery and have not received neoadjuvant therapy
- Having at least one assessable tumor focus
- ECoG physical condition score ≤ 2 points
- Voluntarily participate and sign informed consent
Exclusion
- Patients diagnosed with metastasis
- Patients who cannot obtain tumor samples
- Pregnant and lactating women
- Patients with poor compliance
- Patients with severe cardiovascular and cerebrovascular complications who cannot receive adjuvant treatment
- Patients with other malignant tumors
- Suffering from serious mental and nervous system diseases
- The researchers believe that patients should not be selected for this study
Key Trial Info
Start Date :
February 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05978349
Start Date
February 14 2022
End Date
September 30 2025
Last Update
August 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences
Beijing, China/Beijing, China, 100000